News
VA’S CONVOLUTED PATIENT SCHEDULING STARTS WITH A ‘HELPLINE’ CALL
Veterans trying to schedule medical appointments in the Veterans Affairs Department’s Phoenix Health Care System entered a Kafkaesque world where they had to call a...
News
UF Health successfully implements genomic medicine program
GAINESVILLE, Fla. — At the conclusion of the first year of UF Health’s Personalized Medicine Program, the results are in: The program has successfully implemented...
News
GSK and MMV initiate Phase III programme for development...
GlaxoSmithKline (GSK) and Medicines for Malaria Venture (MMV) have initiated a Phase III global programme to assess the efficacy and safety of tafenoquine, an investigational...
News
Ohr Pharma completes patient enrolment in Phase II trial...
US-based Ohr Pharmaceutical has completed patient enrolment in its OHR-002 Phase II clinical trial evaluating Squalamine Eye Drops for treatment of the wet form of...
News
European Commission grants marketing approval for Teva’s DuoResp Spiromax
Teva Pharmaceutical has obtained marketing authorisation approval from European Commission for its DuoResp Spiromax for treatment of patients with asthma and chronic obstructive pulmonary disease...
News
Bavarian Nordic doses first patient in Phase II trial...
Denmark-based biotechnology firm Bavarian Nordic has dosed first patient in a randomised, prospective Phase II trial of its active immunotherapy product candidate CV-301 for treatment...
News
Janssen’s type 2 diabetes drug Vokanamet gets European Commission...
Janssen-Cilag International (Janssen) has received approval from the European Commission (EC) for use of Vokanamet in the European Union (EU) as a treatment for adults...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.